Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Allarity Therapeutics, Inc. (ALLR)
NASDAQ:ALLR
Holding ALLR?
Track your performance easily
ALLR Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.14 - $38.20
Previous Close$0.18
Volume2.80M
Average Volume (3M)5.92M
Market Cap
$7.75M
Enterprise Value-$8.65M
Total Cash (Recent Filing)$19.23M
Total Debt (Recent Filing)$1.32M
Price to Earnings (P/E)―
Beta1.33
Next Earnings
Oct 08, 2024EPS Estimate
-$0.29Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-74.06
Shares Outstanding42,379,508
10 Day Avg. Volume2,092,242
30 Day Avg. Volume5,918,961
Standard Deviation0.31
R-Squared0.00222
Alpha-0.31
Financial Highlights & Ratios
Price to Book (P/B)0.68
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda2.19
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Allarity Therapeutics, Inc. News
PremiumCompany Announcements
Allarity Therapeutics Shares 2024 Milestones and Vision
PremiumCompany Announcements
Allarity Therapeutics Secures Critical Nasdaq Hearing OpportunityOwnership Overview
0.00%
Insiders
<0.01% Mutual Funds
0.63% Other Institutional Investors
99.37% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
ALLR FAQ
What was Allarity Therapeutics, Inc.’s price range in the past 12 months?
Allarity Therapeutics, Inc. lowest stock price was $0.14 and its highest was $38.20 in the past 12 months.
What is Allarity Therapeutics, Inc.’s market cap?
Currently, no data Available
When is Allarity Therapeutics, Inc.’s upcoming earnings report date?
Allarity Therapeutics, Inc.’s upcoming earnings report date is Oct 08, 2024 which is in 45 days.
How were Allarity Therapeutics, Inc.’s earnings last quarter?
Allarity Therapeutics, Inc. released its earnings results on May 14, 2024. The company reported -$22.14 earnings per share for the quarter, missing the consensus estimate of -$1.76 by -$20.38.
Is Allarity Therapeutics, Inc. overvalued?
According to Wall Street analysts Allarity Therapeutics, Inc.’s price is currently Overvalued.
Does Allarity Therapeutics, Inc. pay dividends?
Allarity Therapeutics, Inc. does not currently pay dividends.
What is Allarity Therapeutics, Inc.’s EPS estimate?
Allarity Therapeutics, Inc.’s EPS estimate is -$0.29.
How many shares outstanding does Allarity Therapeutics, Inc. have?
Allarity Therapeutics, Inc. has 42,379,505 shares outstanding.
What happened to Allarity Therapeutics, Inc.’s price movement after its last earnings report?
Allarity Therapeutics, Inc. reported an EPS of -$22.14 in its last earnings report, missing expectations of -$1.76. Following the earnings report the stock price went down -13.924%.
Which hedge fund is a major shareholder of Allarity Therapeutics, Inc.?
Currently, no hedge funds are holding shares in ALLR
---
Allarity Therapeutics, Inc. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-99.51%
12-Months-Change
Fundamentals
Return on Equity
-121.82%
Trailing 12-Months
Asset Growth
130.02%
Trailing 12-Months
Company Description
Allarity Therapeutics, Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improve clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra.
---
Technical Analysis
---